Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Grossi and Pierluigi Viale.
Connection Strength
0.373
-
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
Score: 0.234
-
Ceftolozane/tazobactam: place in therapy. Expert Rev Anti Infect Ther. 2018 04; 16(4):307-320.
Score: 0.047
-
The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts. J Chemother. 2018 May; 30(3):157-171.
Score: 0.047
-
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother. 2017 Aug; 29(4):197-214.
Score: 0.044